Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Nov 5, 2019, after the close
10-Q filed Nov 5, 2019, 36 days after period end · 0001558370-19-009974
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $20.86M | $4.87M | $900.00K | — |
| Net Income | -$11.49M | -$23.77M | -$17.66M | -$22.63M |
| EPS Diluted |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.07 |
| -$0.14 |
| -$0.14 |
| -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
